M&A Update – Aug 4
– MI-u.to / Crestpoint Real Estate Investments Limited Partnership announced that all closing conditions have been satisfied, closing Aug 6
– GBTG shareholders approved Long Lake Management buyout
– IHS vote
– MI-u.to / Crestpoint Real Estate Investments Limited Partnership announced that all closing conditions have been satisfied, closing Aug 6
– GBTG shareholders approved Long Lake Management buyout
– IHS vote
– NBGR announced a business combination with Startech
– THEOU $125 million IPO
– FJDIU $105 million IPO
– SVSXU filed S-1 for $150 million IPO
– HVII filed 424b3 for ONE Nuclear Energy deal, vote Aug 24
– VACI filed F-4/a for NorthStar deal
– CCAQ extension vote
– FDMMU split
– LNTH to be acquired by Curium for $102.50 cash + CVR worth up to $12.00 per share, 8.5% premium, $8.0 billion
– ITGR to be acquired by KKR for $127.00 cash per share, 51.8% premium, $5.7 billion
– ATKR to be acquired by PRY for $95.00 cash per share, 56.5% premium, $3.8 billion
– SUPN to be acquired by INDV for 1.5401x shares less $1 billion dividend paid, 19.0% premium, $2.7 billion
– BOW to be acquired by American Family Mutual Insurance Company for $34.00 cash per share, 11.1% premium, $1.2 billion
– EA / PIF / Silver Lake / Affinity Partners filed delisting notice, closing Aug 4
– MDV / GNL filed delisting notice, closing Aug 12
– PAYO / Nuvei filed PREM14a, cleared HSR July 28, closing mid 2027
– ACA / CRH filed DEFM14a, vote Sept 4, filed HSR July 6, closing Q1 2027
– CRNX / VRTX filed DEFM14a, vote Aug 28, closing Q3 2026
– ALOT / Arcline Investment Management filed DEFM14a, vote Aug 25
– GSAT / AMZN filed S-4, cleared HSR July 17, closing in 2027
– QRVO / SWKS cleared HSR
– GBTG vote
– TSX closed
– BLRK announced a business combination with Yellow.ai
– ANSC to liquidate Aug 13, NAV $11.47
– GXTRU filed S-1 for $200 million IPO
– RFAI filed DEF14a to extend deadline to Feb 15 2027, vote Aug 12, NAV $11.07
– CAPN filed F-4/a for Mango Financial deal
– VACI filed F-4/a for NorthStar deal
– BBCQ filed F-4/a for Pasqal deal
– BKHA filed S-4/a for Vesicor Therapeutics deal
– OCACU split

Research up-to-date NAVs, yields, pricing, deadlines, in-depth notes on each SPAC outstanding along with all business combinations, and more.

Discover deal structure, yields, odds of closing, conditions, in-depth notes on each M&A deal, and more.

Track the most current and relevant news and filings for all SPAC and M&A opportunities.